loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 204028 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 DESVENLAFAXINE SUCCINATE (3)

filter

01 RUBICON (3)

filter

01 TABLET, EXTENDED RELEASE;ORAL (3)

filter

01 EQ 100MG BASE (1)

02 EQ 25MG BASE (1)

03 EQ 50MG BASE (1)

filter

01 USA (3)

URL Supplier Web Content
TABLET, EXTENDED RELEA...
EQ 25MG BASE
DESVENLAFAXINE SUCCINA...
USA
204028
2023-12-07
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, EXTENDED RELEA...
EQ 50MG BASE
DESVENLAFAXINE SUCCINA...
USA
204028
2015-06-29
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, EXTENDED RELEA...
EQ 100MG BASE
DESVENLAFAXINE SUCCINA...
USA
204028
2015-06-29
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 204028

Looking for CTD TGA MCC DOSSIER APPLICATION 204028 3

19

Rubicon Research Pvt. Ltd., based in India, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is DESVENLAFAXINE SUCCINATE, with a corresponding application number 204028 and regulatory information .

proudly manufactured in the

approval since 2023-12-07

Rubicon Research Pvt. Ltd.'s DESVENLAFAXINE SUCCINATE TABLET, EXTENDED RELEASE;ORAL, medication with EQ 25MG BASE of DESVENLAFAXINE SUCCINATE.

18

Rubicon Research Pvt. Ltd., based in India, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is DESVENLAFAXINE SUCCINATE, with a corresponding application number 204028 and regulatory information .

proudly manufactured in the

approval since 2015-06-29

Rubicon Research Pvt. Ltd.'s DESVENLAFAXINE SUCCINATE TABLET, EXTENDED RELEASE;ORAL, medication with EQ 50MG BASE of DESVENLAFAXINE SUCCINATE.

17

Rubicon Research Pvt. Ltd., based in India, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is DESVENLAFAXINE SUCCINATE, with a corresponding application number 204028 and regulatory information .

proudly manufactured in the

approval since 2015-06-29

Rubicon Research Pvt. Ltd.'s DESVENLAFAXINE SUCCINATE TABLET, EXTENDED RELEASE;ORAL, medication with EQ 100MG BASE of DESVENLAFAXINE SUCCINATE.

Post Enquiry
POST ENQUIRY